Select Committee on Science and Technology Appendices to the Minutes of Evidence


Annex C

SIXTH FRAMEWORK PROGRAMME 2002-06

  
Types of Activity
Millions
of Euros
%
1
FOCUSSING AND INTEGRATING COMMUNITY RESEARCH
13,345
76.3
  
THEMATIC PRIORITIES1
11,285
64.5
      
LIFE SCIENCES, GENOMICS AND BIOTECHNOLOGY FOR HEALTH
2,255
12.9
  
—Advanced genomics and its applications for health
1,100
6.3
  
—Combating major diseases2
1,155
6.6
  
INFORMATION SOCIETY TECHNOLOGIES3
3,625
20.7
  
NANOTECHNOLOGIES AND NANOSCIENCES, KNOWLEDGE-BASED MULTIFUNCTIONAL MATERIALS AND NEW PRODUCTION PROCESSES AND DEVICES
1,300
7.4
  
AERONAUTICS AND SPACE
1,075
6.1
  
FOOD QUALITY AND SAFETY
685
3.9
  
SUSTAINABLE DEVELOPMENT, GLOBAL CHANGE AND ECOSYSTEMS
2,120
12.1
  
—Sustainable energy systems
810
4.6
  
—Sustainable surface transport
610
3.5
  
—Global change and ecosystems
700
4.0
  
CITIZENS AND GOVERNANCE IN A KNOWLEDGE-BASED SOCIETY
225
1.3
  
Specific activities covering a wider field of research
1,300
7.4
  
—Supporting policies and anticipating scientific and technological needs
555
3.2
  
—Horizontal research activities involving SMEs
430
2.5
  
—Specific measures in support of international co-operation4
315
1.8
  
Non-nuclear activities of the Joint Research Centre
760
4.3
2
STRUCTURING THE EUROPEAN RESEARCH AREA
2,605
14.9
  
Research and innovation
290
1.7
  
Human resources and mobility
1,580
9.0
  
Research infrastructures5
655
3.7
  
Science and society
80
0.5
3
STRENGTHENING THE FOUNDATIONS OF THE EUROPEAN RESEARCH AREA
320
1.8
  
Support for the co-ordination of activities
270
1.5
  
Support for the coherent development of policies
50
0.3
4
RESEARCH AND TRAINING IN THE NUCLEAR FIELD (EURATOM TREATY)
1,230
7.0
  
Priority thematic fields of research
890
5.0
  
—Controlled thermonuclear fusion
750
4.3
  
—Management of radioactive waste
90
0.5
  
—Radioprotection
50
0.3
  
Other activities in the field of technologies and nuclear safety
50
0.3
  
Activities of the Joint Research Centre
290
1.7
  
TOTAL
17,500
100


  1  Of which at least 15 per cent aimed for SMEs.

  2  Including up to EUR 400 million for cancer-related research.

  3  Including up to 100 million for the continued development of Géant and GRID.

  4  This amount of EUR 315 million will fund specific measures in support of international cooperation involving developing countries, Mediterranean countries including the Western Balkans, and Russia and the Newly Independent States (NIS). Another EUR 285 million is earmarked to finance the participation of third country organisations in the `Thematic Priorities' and in the `Specific activities covering a wider field of research', thus bringing the total amount devoted to international cooperation to EUR 600 million. Additional resources will be available under section 2.2 `Human resources and mobility' to fund research training for third country researchers in Europe.

  5  Including up to EUR 200 million for continuation of the Géant and GRID projects.


 
previous page contents

House of Commons home page Parliament home page House of Lords home page search page enquiries index

© Parliamentary copyright 2002
Prepared 6 November 2002